CG Oncology Inc.
- CGON
- NASDAQ
- Biotechnology
- Bladder Cancer Therapy
- Oncolytic Immunotherapy
$59.85
Today −3.25%Quote Oct 16, 2026, 08:00 PM UTC
−20.85%over the last month
Max drawdown −23.5%From 1-month high −23.5%3 months −14.7%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$5.31B
Quote Oct 16
Next earnings
Nov 13
Expected, not confirmed
Analyst target
$86.50
+44.5% from here
Floor
$56.64
5.4% below price
Where the price sits
10 analysts
Analyst range, low to high
$80.00$100.00
- Price $59.85
- Resistance $60.23
- Consensus $86.50
The price is right under resistance. Analysts' average target sits about 45% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about CGONPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
142
Founded
2010